Page 25 - Tata_Chemicals_yearly-reports-2020-2021
P. 25

Integrated Report   Statutory Reports  Financial Statements
 Integrated Annual Report 2020-21  Risk Management  60-146  147-300




 strategic Risks  operational Risks

 Mitigation
   IT strategy and IT roadmap has been created with clear timelines  Mitigation
   Architecture board setup to drive cohesive enterprise level IT/Digital    4.  Cyber Risk     Best-in-class cyber-security managed services. Under this programme, we will have
 2.  Digitalisation Risks  decision-making and solution design  24x7 monitoring of security logs of IT assets and highlighting of key risks
     Failure to embrace digitalisation     IT team has been restructured to achieve harmonisation and standardisation in terms   Loss of data & compromised     We conduct regular third party VAPT assessments to check for vulnerabilities
 as a key lever of Business Growth  of global digital landscape  operations resulting from Cyber     IT policies have been updated based on ISO & ITIL standards
   Various digital initiatives are undertaken to improve operations, serve the customers in   attacks
 Linkage to Capital  a better way & collaborate with suppliers, transporters, external business partners  Linkage to Capital    Cyber security awareness sessions for employees
 Intellectual Capital    All projects and initiatives are reviewed in different forums like weekly, monthly,     Cyber insurance policy at corporate level
 quarterly governance reviews to ensure that timelines are met  Manufactured Capital    Cyber security risks are periodically reviewed by the Risk Management Committee of
   Annual assessment is done to assess the digital maturity level of the Company and   the Board
 actions are taken to improve the score


 Mitigation
 soda Ash & silica
   Introduction of new variants and brands with differentiated offerings
 3.  Product Portfolio Risk    Identification and introduction of new value-added products as downstream of
 Failure to develop a portfolio of   existing product lines
 high value products thus eroding     Identification and introduction of new high value products to substitute imports and
 competitive position  for targeting export markets
 salt, sodium Bicarbonate & Prebiotics
   Creation of a common customer-facing team across all product categories in
 Nutrition across food, pharma and feed customer segments
   Development of new value-added products through application development and
 Linkage to Capital  formulations
 Manufactured Capital,     Expanding current product with new ingredients
 Intellectual Capital    Entry into new segments for growth in inorganic chemistry and extraction /
 fermentation technology platforms
   Enhancing scientific capabilities in areas of growth and supporting customers with
 scientific data and claims  Financial Risks
 Crop Care and seeds
   Enrich portfolio with new off-patent active ingredients  Mitigation
   Optimising product registration cycle time by fast tracking pilot plant level scale-up     Continuous monitoring of cash flows with focus on the safety & liquidity of the
   Adopting emerging technologies in breeding for optimal cycle time and outcomes  5.   Capital Allocation Risk   investments
   Appropriate resourcing for tapping contract manufacturing opportunities by   Failure to utilise capital efficiently and      Rigorous capital investment programme, focussing adding economic value and
 leveraging chemistry strength                   improving ROCE
 Innovation   cost effectively due to indisciplined     To evaluate and refinance the applicable loan facilities proactively by proactive
              capital allocation leading to
    Ensuring high quality innovation pipeline that fuels growth for new & existing   unfavourable returns to stakeholders  use of debt and capital markets towards reducing refinance risks and to support a
 business on continuous basis                    healthy cash flow
   Ensure progress on the R&D long-term plan   Linkage to Capital
   Encourage synergies between all the R&D streams, including external Collaborations   Financial Capital     Preserving cash through host of new initiatives including further focus and
 with Leading Indian and Global R&D Centres      balanced efforts towards containment of fixed cost across plant and non-plant
   Ensure R&D focus balancing between Business-led Science differentiation and Next   activities, working capital
 Generation projects
   Build Centre of Excellence to cater the computational and analytical requirements of
 R&D centres and enhance their effectiveness
   Shorten registration time for Agro Chemicals and improve the robustness of traits
 development in Hybrid Seeds



 22                                                                                                         23
   20   21   22   23   24   25   26   27   28   29   30